```json
{
"content": [
{
"type": "paragraph",
"content": "The Type segmentation of the PET-MRI System for Brain Scan market is principally divided into three architectures: Hybrid PET-MRI (simultaneous acquisition within a single gantry), Sequential PET-MRI (separate scanners linked by a common patient table), and Integrated PET-MRI (PET detector inserted into an MRI bore without full system merger). Hybrid systems command the largest revenue share because they eliminate patient transfer time, thereby increasing throughput and reducing motion artifacts, which directly expands market size. Sequential configurations retain a niche share, favored in facilities retrofitting existing MRI assets, contributing modestly to overall growth through lower capital outlay. Integrated designs, while technologically complex, attract high‑end research institutions seeking maximal spatial resolution; their premium pricing adds a disproportionate value to the market despite limited unit volumes. Collectively, these type categories delineate investment pathways and forecast the capital allocation trends that shape the PET-MRI System for Brain Scan market."
},
{
"type": "paragraph",
"content": "The Application segmentation, a core element of PET-MRI System for Brain Scan segmentation, comprises three primary use‑cases: Neurodegenerative disease diagnosis (Alzheimer's, Parkinson's), Brain tumor characterization (glioma grading, treatment monitoring), and Cognitive research (functional connectivity, drug efficacy trials). Neurodegenerative diagnostics drive the bulk of clinical adoption, as combined metabolic and structural imaging improves early detection, thereby accounting for the highest percentage of market revenue. Brain tumor characterization leverages PET’s metabolic specificity and MRI’s anatomical detail, supporting surgical planning and radiotherapy, which contributes a substantial secondary share to market size. Cognitive research, though smaller in absolute sales, commands high per‑unit pricing due to specialized protocols and regulatory requirements, adding a strategic premium to the overall market. These application segments collectively define demand drivers and inform product development priorities across the PET-MRI System for Brain Scan market."
}
],
"chartData": {
"segments": [
{ "name": "Neurodegenerative disease diagnosis", "value": fifty },
{ "name": "Brain tumor characterization", "value": thirty },
{ "name": "Cognitive research", "value": twenty }
]
}
}
```
